Alpha memo: creatine context boundary

Artifact

Agent-certified evidence map from agent-v6-alpha-eval-20260626230706

Reviewer panel scores

Review verdicts

Why

Review decision

To resubmit, address

1. Reconcile the alpha sentence with the bundle: Receipt 2 does cover brain/cognitive contexts (cerebral creatine deficiency syndrome), so revise the 'context-dependent' framing to specify that the contrast is primarily between acute cognitive endpoints in healthy young adults (null, Receipt 1) versus body composition, high-intensity performance, and chronic clinical conditions (positive, Receipt 2), rather than implying creatine's cognitive signal is uniformly null.
2. Incorporate the actual Receipt 1 results from the supplied excerpt: null effect on cognitive performance; trend for decreased relative PFC O2Hb in CR10 vs PLA on processing speed (p=0.06); and the conclusion that 6 weeks at moderate or high dose does not improve cognition or PFC activation.
3. Flag the anomalous 2026 publication year on Receipt 2 as a likely metadata error and note the review's low-tier evidence weight relative to Receipt 1's RCT.
4. Narrow or relabel the domain anchor: if the memo is about a cognitive-null vs. athletic-positive contrast, reflect that in the title/topic rather than a generic 'creatine context boundary'.

Major issues

• The memo treats Receipt 2 (a broad narrative review of athletic and clinical creatine benefits) as a direct contrast to Receipt 1 (a cognitive RCT). The 'context-dependent' framing conflates endpoint family with context, but Receipt 2 explicitly includes brain/cognitive claims (e.g., cerebral creatine deficiency syndrome), so the claim that cognitive signal is bounded while athletic/clinical signal is uniformly positive is not cleanly supported by the paired bundle.
• Receipt 2's year is listed as 2026 in the source bundle but this is likely an erroneous openAlex metadata date; the memo should not rely on a future-dated review without flagging it. The memo does not flag this.

Minor issues

• The alpha sentence asserts Receipt 2 'reviews the broader athletic and therapeutic promise' but the supplied excerpt is a narrative review with broad, non-quantified claims; the memo should explicitly note Receipt 2 is low-evidence-weight relative to Receipt 1's RCT design.
• Receipt 1's excerpt confirms the null cognitive finding and the trend-level PFC O2Hb result (p=0.06), but the memo body says 'full numeric results not verified from supplied snippet' — this is inaccurate given the excerpt is available in the bundle.
• The domain_slug is 'longevity_research' but the memo's central anchor is acute cognitive endpoints in healthy young adults, which is a weak fit for a longevity framing.

Reviewer note

The memo attempts a bounded two-receipt contrast between an acute cognitive RCT (null in healthy young adults) and a broad narrative review of athletic/clinical creatine benefits. The pairing is reasonable as a starting point and Receipt 1's null cognitive finding is accurately characterized once the excerpt is consulted. However, the alpha framing overstates the contrast: Receipt 2 explicitly covers brain/cognitive domains (e.g., cerebral creatine deficiency syndrome), so claiming creatine's signal is 'context-dependent' with a uniform cognitive-null reading is not cleanly supported by the bundle. The memo also omits Receipt 1's actual numeric findings available in the excerpt (null cognitive effect, p=0.06 trend on PFC O2Hb) and does not flag Receipt 2's anomalous 2026 date. Limitations and falsifiers are well specified, and source grounding is adequate given the receipt pairing, but the central claim needs narrower scoping. Revise is warranted to tighten the context-dependent framing and incorporate available numeric details.

Panel metadata

Models: MiniMax-M3 + google/gemma-4-31b-it + mistralai/mistral-small-2603

Route: fallback_tiebreak_failed_conservative

Prompt: reviewer-v11-research-synthesis